相似文献
1
Platelet--cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation.
Br J Pharmacol. 2004 Dec;143(7):819-26. doi: 10.1038/sj.bjp.0706013. Epub 2004 Oct 18.
2
Elucidation of flow-mediated tumour cell-induced platelet aggregation using an ultrasound standing wave trap.
Br J Pharmacol. 2011 Apr;162(7):1577-89. doi: 10.1111/j.1476-5381.2010.01182.x.
3
Identification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasis.
Oncotarget. 2015 Dec 15;6(40):42733-48. doi: 10.18632/oncotarget.5811.
4
Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.
Cancer Res. 2001 Jan 1;61(1):376-82.
5
Differential inhibition of tumour cell-induced platelet aggregation by the nicotinate aspirin prodrug (ST0702) and aspirin.
Br J Pharmacol. 2012 Jun;166(3):938-49. doi: 10.1111/j.1476-5381.2011.01794.x.
6
Downregulation of Integrins in Cancer Cells and Anti-Platelet Properties Are Involved in Holothurian Glycosaminoglycan-Mediated Disruption of the Interaction of Cancer Cells and Platelets in Hematogenous Metastasis.
J Vasc Res. 2015;52(3):197-209. doi: 10.1159/000439220. Epub 2015 Oct 22.
7
Inhibition of the interactions between metastatic human breast cancer cells and platelets by β-nitrostyrene derivatives.
Life Sci. 2015 Dec 15;143:147-55. doi: 10.1016/j.lfs.2015.11.003. Epub 2015 Nov 10.
8
Tumor cell-induced platelet aggregation in vitro by human pancreatic cancer cell lines.
Scand J Gastroenterol. 1995 Oct;30(10):1008-16. doi: 10.3109/00365529509096346.
9
Characterization of platelet aggregation induced by human colon adenocarcinoma cells and its inhibition by snake venom peptides, trigramin and rhodostomin.
Br J Haematol. 1994 Jun;87(2):325-31. doi: 10.1111/j.1365-2141.1994.tb04917.x.
10
Signaling pathways for induction of platelet aggregation by SAS tongue cancer cells--a mechanism of hematogenous metastasis.
J Oral Pathol Med. 2009 May;38(5):434-40. doi: 10.1111/j.1600-0714.2008.00701.x. Epub 2008 Sep 22.
引用本文的文献
1
Antiplatelet Therapy Mitigates Brain Metastasis Risk in Non-Small Cell Lung Cancer: Insights from a Comprehensive Retrospective Study.
Cancers (Basel). 2025 Jun 20;17(13):2059. doi: 10.3390/cancers17132059.
2
HISLIS: Histology, Sarcopenia, and Lung Inflammation Score-A New Perspective for Lung Cancer Patients?
Life (Basel). 2025 Jun 16;15(6):963. doi: 10.3390/life15060963.
3
Direct Oral Anticoagulants Are Comparable to Low Molecular Weight Heparin at Sustaining the Circulating Extracellular Vesicle and Inflammatory Profiles of Cancer Associated Thrombosis Patients: An Observational Pilot Study.
Cancer Med. 2025 May;14(9):e70920. doi: 10.1002/cam4.70920.
4
Utilizing Albumin Value, HALP Score and LCR Value for Predicting Survival in Patients with Pancreatic Adenocarcinoma.
Medicina (Kaunas). 2025 Apr 1;61(4):639. doi: 10.3390/medicina61040639.
5
Transcriptomic profiling of blood platelets identifies a diagnostic signature for pancreatic cancer.
Br J Cancer. 2025 Jun;132(10):937-946. doi: 10.1038/s41416-025-02980-z. Epub 2025 Mar 25.
6
Effect of mono-guanidine-like derivatives on platelet aggregation and tumour cell induced platelet aggregation.
RSC Med Chem. 2025 Jan 31;16(4):1695-1704. doi: 10.1039/d4md00793j. eCollection 2025 Apr 16.
7
Effect of Hemoglobin, Albumin, Lymphocyte Count, and Platelet (HALP) Score on Survival of Patients with Metastatic Thyroid Cancer Treated with Tyrosine Kinase Inhibitors.
J Clin Med. 2025 Feb 16;14(4):1306. doi: 10.3390/jcm14041306.
8
Correlation Between Intravascular Platelet Aggregation in Tumors and Hypoxia-Inducible Factor 1 Alpha Expression in Epithelial Ovarian Cancer: Implications for Prognosis and Staging.
Cancers (Basel). 2025 Jan 21;17(3):345. doi: 10.3390/cancers17030345.
9
F-FAPI-42 PET/CT for preoperatively identifying intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
Quant Imaging Med Surg. 2025 Jan 2;15(1):741-751. doi: 10.21037/qims-24-1489. Epub 2024 Dec 18.
10
Prognostic value of the HALP score in metastatic castration-resistant prostate cancer: an analysis combined with time to castration resistance.
Front Oncol. 2024 Dec 5;14:1431629. doi: 10.3389/fonc.2024.1431629. eCollection 2024.
本文引用的文献
1
Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk.
JAMA. 2004 May 26;291(20):2433-40. doi: 10.1001/jama.291.20.2433.
2
Matrix metalloproteinase-2 contributes to increased platelet reactivity in patients with metastatic prostate cancer: a preliminary study.
Thromb Res. 2003;112(1-2):59-64. doi: 10.1016/j.thromres.2003.10.012.
3
Low-molecular-weight heparins: beyond thrombosis in the management of the cancer patient.
Semin Thromb Hemost. 2003 Dec;29 Suppl 1:13-5. doi: 10.1055/s-2003-45412.
4
Correlation of platelet count with second-look laparotomy results and disease progression in patients with advanced epithelial ovarian cancer.
Obstet Gynecol. 2004 Jan;103(1):82-5. doi: 10.1097/01.AOG.0000102703.21556.0B.
5
Membrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: role of receptor glycoproteins.
Br J Pharmacol. 2004 Jan;141(2):241-52. doi: 10.1038/sj.bjp.0705606. Epub 2003 Dec 22.
6
Platelet and osteoclast beta3 integrins are critical for bone metastasis.
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14205-10. doi: 10.1073/pnas.2234372100. Epub 2003 Nov 11.
7
Coagulopathic complications in breast cancer.
Cancer. 2003 Oct 15;98(8):1578-86. doi: 10.1002/cncr.11702.
8
Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas.
J Clin Invest. 2003 Sep;112(6):853-62. doi: 10.1172/JCI18882.
9
Tissue factor, thrombin, and cancer.
Chest. 2003 Sep;124(3 Suppl):58S-68S. doi: 10.1378/chest.124.3_suppl.58s.
10
Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454.
Thromb Haemost. 2003 Sep;90(3):549-54. doi: 10.1160/TH03-02-0102.
Zotero 插件